Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John S Oxford

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Biologist (London, England)|April 5, 2002
Influenza A: a threatening virus with two facesJohn S Oxford
Influenza and Other Respiratory Viruses|May 21, 2009
Antivirals for the treatment and prevention of epidemic and pandemic influenzaJohn S Oxford
British Journal of Clinical Pharmacology|April 27, 2013
Towards a universal influenza vaccine: volunteer virus challenge studies in quarantine to speed the development and subsequent licensingJohn S Oxford
The Lancet. Infectious Diseases|June 25, 2018
Unanswered questions about the 1918 influenza pandemic: origin, pathology, and the virus itselfJohn S Oxford, Douglas Gill
Human Vaccines & Immunotherapeutics|May 24, 2019
A possible European origin of the Spanish influenza and the first attempts to reduce mortality to combat superinfecting bacteria: an opinion from a virologist and a military historianJohn S Oxford, Douglas Gill
Human Vaccines & Immunotherapeutics|August 14, 2020
Vaccines from the Spanish Influenza as a firm foundation for new developmentsJohn S Oxford, Douglas Gill
Expert Review of Vaccines|September 26, 2012
Clinical, scientific and ethnographic studies of influenza in quarantineJohn S Oxford, Juliette R Oxford
Journal of Neuropathology and Experimental Neurology|January 30, 2004
Immunogold electron microscopy recognizes prion protein-associated particles prepared from scrapie-infected mouse brainRobert R Dourmashkin, John S Oxford, Lynne Bountiff
Antiviral Chemistry & Chemotherapy|December 24, 2002
New millennium antivirals against pandemic and epidemic influenza: the neuraminidase inhibitorsJohn S Oxford, Patricia Novelli, Armine Sefton, et al.
Viral Immunology|March 22, 2008
Lack of evidence for complete resistance of peripheral blood mononuclear cells to HIV-1 and HIV-2 infectionAli A Al-Jabri, Robert Lambkin, John S Oxford
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Biologist (London, England)|April 5, 2002
Influenza A: a threatening virus with two facesJohn S Oxford
Influenza and Other Respiratory Viruses|May 21, 2009
Antivirals for the treatment and prevention of epidemic and pandemic influenzaJohn S Oxford
British Journal of Clinical Pharmacology|April 27, 2013
Towards a universal influenza vaccine: volunteer virus challenge studies in quarantine to speed the development and subsequent licensingJohn S Oxford
The Lancet. Infectious Diseases|June 25, 2018
Unanswered questions about the 1918 influenza pandemic: origin, pathology, and the virus itselfJohn S Oxford, Douglas Gill
Human Vaccines & Immunotherapeutics|May 24, 2019
A possible European origin of the Spanish influenza and the first attempts to reduce mortality to combat superinfecting bacteria: an opinion from a virologist and a military historianJohn S Oxford, Douglas Gill
Human Vaccines & Immunotherapeutics|August 14, 2020
Vaccines from the Spanish Influenza as a firm foundation for new developmentsJohn S Oxford, Douglas Gill
Expert Review of Vaccines|September 26, 2012
Clinical, scientific and ethnographic studies of influenza in quarantineJohn S Oxford, Juliette R Oxford
Journal of Neuropathology and Experimental Neurology|January 30, 2004
Immunogold electron microscopy recognizes prion protein-associated particles prepared from scrapie-infected mouse brainRobert R Dourmashkin, John S Oxford, Lynne Bountiff
Antiviral Chemistry & Chemotherapy|December 24, 2002
New millennium antivirals against pandemic and epidemic influenza: the neuraminidase inhibitorsJohn S Oxford, Patricia Novelli, Armine Sefton, et al.
Viral Immunology|March 22, 2008
Lack of evidence for complete resistance of peripheral blood mononuclear cells to HIV-1 and HIV-2 infectionAli A Al-Jabri, Robert Lambkin, John S Oxford
Pageof 3